Ligand validation:5NCG

8TB: (3~{S},7~{R},10~{R},11~{R},13~{S})-4-[(3~{S},6~{R},8~{a}~{S})-1'-[(2~{S})-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8~{a}-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-11-methyl-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid

8TB is a Ligand Of Interest in 5NCG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NCG_8TB_A_201	94%	13%	0.077	0.976	2.03	2.15	14	15	0	0	100%	0.95
5NCG_8TB_B_202	89%	9%	0.091	0.969	2.16	2.46	12	14	0	0	100%	0.57
5NCG_8TB_B_201	89%	9%	0.096	0.974	2.18	2.52	13	15	0	0	100%	0.54
5NCG_8TB_A_202	89%	7%	0.097	0.975	2.28	2.79	12	15	0	0	100%	0.29
5NCG_8TB_A_203	87%	13%	0.095	0.969	2.04	2.12	10	14	0	0	100%	0.76

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.